

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.45164032 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.45164032 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.70098029 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.49978257 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.20449316 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.89101672 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.80412051 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.61931987 |
| 9 | leukocyte aggregation (GO:0070486) | 4.61280881 |
| 10 | negative regulation of interleukin-12 production (GO:0032695) | 4.46779309 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.39509778 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.39509778 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.39509778 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.39509778 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.39509778 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.39509778 |
| 17 | T cell migration (GO:0072678) | 4.33089367 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.31749783 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.24596815 |
| 20 | response to peptidoglycan (GO:0032494) | 4.15583711 |
| 21 | detection of other organism (GO:0098543) | 4.15033552 |
| 22 | response to interleukin-15 (GO:0070672) | 4.10102085 |
| 23 | detection of bacterium (GO:0016045) | 4.04489298 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 4.03601989 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.98185192 |
| 26 | response to muramyl dipeptide (GO:0032495) | 3.97496093 |
| 27 | tolerance induction (GO:0002507) | 3.95709983 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.95159272 |
| 29 | cellular response to type I interferon (GO:0071357) | 3.89380139 |
| 30 | type I interferon signaling pathway (GO:0060337) | 3.89380139 |
| 31 | response to type I interferon (GO:0034340) | 3.86269637 |
| 32 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84479034 |
| 33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.77122196 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.77003577 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.74361397 |
| 36 | cellular extravasation (GO:0045123) | 3.69980149 |
| 37 | negative T cell selection (GO:0043383) | 3.67241757 |
| 38 | neutrophil activation (GO:0042119) | 3.66421334 |
| 39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.63429242 |
| 40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.62784822 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61940113 |
| 42 | defense response to protozoan (GO:0042832) | 3.60943566 |
| 43 | germinal center formation (GO:0002467) | 3.59649950 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.58343216 |
| 45 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.57077111 |
| 46 | granulocyte activation (GO:0036230) | 3.49198082 |
| 47 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.48254766 |
| 48 | positive thymic T cell selection (GO:0045059) | 3.37199931 |
| 49 | detection of external biotic stimulus (GO:0098581) | 3.36795679 |
| 50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.34843572 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 3.32597424 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.32163106 |
| 53 | negative regulation of innate immune response (GO:0045824) | 3.31840292 |
| 54 | response to protozoan (GO:0001562) | 3.30154295 |
| 55 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.30134417 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29805751 |
| 57 | respiratory burst (GO:0045730) | 3.26631857 |
| 58 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.19145718 |
| 59 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.16797297 |
| 60 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.16797297 |
| 61 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16356389 |
| 62 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14599616 |
| 63 | mast cell activation (GO:0045576) | 3.13771872 |
| 64 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.12750433 |
| 65 | regulation of tolerance induction (GO:0002643) | 3.11345719 |
| 66 | dendritic cell chemotaxis (GO:0002407) | 3.10228945 |
| 67 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.09997320 |
| 68 | detection of molecule of bacterial origin (GO:0032490) | 3.08458921 |
| 69 | B cell receptor signaling pathway (GO:0050853) | 3.08338461 |
| 70 | regulation of interferon-alpha production (GO:0032647) | 3.07156775 |
| 71 | leukocyte degranulation (GO:0043299) | 3.05188957 |
| 72 | negative regulation of type 2 immune response (GO:0002829) | 3.04350187 |
| 73 | lymphocyte chemotaxis (GO:0048247) | 3.02816076 |
| 74 | regulation of mast cell degranulation (GO:0043304) | 3.02260513 |
| 75 | negative regulation of interleukin-6 production (GO:0032715) | 3.01360143 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.01256576 |
| 77 | B cell mediated immunity (GO:0019724) | 3.00861441 |
| 78 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.00647455 |
| 79 | regulation of antigen processing and presentation (GO:0002577) | 2.99095825 |
| 80 | positive regulation of type 2 immune response (GO:0002830) | 2.98779036 |
| 81 | response to host immune response (GO:0052572) | 2.97614998 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.97614998 |
| 83 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.97056734 |
| 84 | detection of biotic stimulus (GO:0009595) | 2.96710400 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94177284 |
| 86 | positive regulation of interferon-alpha production (GO:0032727) | 2.93179880 |
| 87 | positive T cell selection (GO:0043368) | 2.92886810 |
| 88 | T cell selection (GO:0045058) | 2.91137186 |
| 89 | regulation of B cell differentiation (GO:0045577) | 2.89328454 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.88542857 |
| 91 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88214105 |
| 92 | regulation of type 2 immune response (GO:0002828) | 2.86997548 |
| 93 | thymic T cell selection (GO:0045061) | 2.86733683 |
| 94 | dendritic cell migration (GO:0036336) | 2.85876563 |
| 95 | regulation of cell killing (GO:0031341) | 2.85826169 |
| 96 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84993780 |
| 97 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.83615202 |
| 98 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.83612258 |
| 99 | regulation of regulatory T cell differentiation (GO:0045589) | 2.83386879 |
| 100 | regulation of leukocyte degranulation (GO:0043300) | 2.82946986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.85440704 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.48967034 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.36375017 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.23893121 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.01905283 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.61128244 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.39916071 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.21485380 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05639796 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.04990565 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.93872995 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.85434027 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64861268 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.57930093 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56999833 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.56369311 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51316474 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.47458159 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42802793 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.40856645 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.37277233 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.36394185 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31908310 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.29695259 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24894091 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22883441 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.20084717 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 2.19861939 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.17831707 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15322840 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 2.13179932 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.10124494 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04205549 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02435392 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99896812 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95194517 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.89294591 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83471275 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83331288 |
| 40 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78842538 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66140683 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.64606494 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63699016 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62277537 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57458679 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57445617 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54273431 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54239292 |
| 49 | GATA3_26560356_Chip-Seq_TH2_Human | 1.53234562 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52686232 |
| 51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52495279 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46525332 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.45915231 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43594605 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42115123 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.40821548 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40287391 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39155115 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38961088 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36926868 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36888593 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30730054 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30457536 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26935719 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25117379 |
| 66 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24336466 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24335048 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23961055 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21156272 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20855975 |
| 71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17972819 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16931499 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16511457 |
| 74 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15967662 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14716376 |
| 76 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13759373 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13523564 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13165358 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11915308 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11457550 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10488318 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09743321 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09074460 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08611287 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05492529 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00793804 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00538022 |
| 88 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99714143 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97781159 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96716703 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93999563 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92268409 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89996053 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87082830 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84100059 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83971042 |
| 97 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83500030 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83198561 |
| 99 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81706611 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78731762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.75731483 |
| 2 | MP0003436_decreased_susceptibility_to | 4.41796702 |
| 3 | MP0003303_peritoneal_inflammation | 4.14326937 |
| 4 | MP0005671_abnormal_response_to | 3.74474362 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.63838692 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.26024955 |
| 7 | MP0009785_altered_susceptibility_to | 3.25838369 |
| 8 | MP0001800_abnormal_humoral_immune | 3.07565016 |
| 9 | MP0001790_abnormal_immune_system | 3.04539547 |
| 10 | MP0005387_immune_system_phenotype | 3.04539547 |
| 11 | MP0002419_abnormal_innate_immunity | 2.93068809 |
| 12 | MP0005025_abnormal_response_to | 2.90876618 |
| 13 | MP0002723_abnormal_immune_serum | 2.79321525 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.78279767 |
| 15 | MP0000685_abnormal_immune_system | 2.70194146 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.65919943 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.61655206 |
| 18 | MP0006082_CNS_inflammation | 2.60389045 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.55654994 |
| 20 | MP0001819_abnormal_immune_cell | 2.54851110 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.45722332 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.33123458 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.15167156 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.08246057 |
| 25 | MP0004947_skin_inflammation | 2.06721928 |
| 26 | MP0002405_respiratory_system_inflammati | 2.03859841 |
| 27 | MP0002398_abnormal_bone_marrow | 1.95712988 |
| 28 | MP0000716_abnormal_immune_system | 1.94349796 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.92933487 |
| 30 | MP0004510_myositis | 1.81810956 |
| 31 | MP0009764_decreased_sensitivity_to | 1.77539047 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.76324374 |
| 33 | MP0009278_abnormal_bone_marrow | 1.72554566 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.65529502 |
| 35 | MP0003866_abnormal_defecation | 1.60422411 |
| 36 | MP0002722_abnormal_immune_system | 1.60409210 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.59926431 |
| 38 | MP0008469_abnormal_protein_level | 1.55367413 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.53377668 |
| 40 | MP0002429_abnormal_blood_cell | 1.51699201 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.39030062 |
| 42 | MP0005310_abnormal_salivary_gland | 1.34775489 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.34462079 |
| 44 | MP0000858_altered_metastatic_potential | 1.33892275 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.32657222 |
| 46 | MP0005451_abnormal_body_composition | 1.30914509 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.29605319 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.28533574 |
| 49 | MP0003075_altered_response_to | 1.22727374 |
| 50 | MP0003448_altered_tumor_morphology | 1.17362106 |
| 51 | MP0001873_stomach_inflammation | 1.16348399 |
| 52 | MP0008260_abnormal_autophagy | 1.16136311 |
| 53 | MP0004381_abnormal_hair_follicle | 1.15609957 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.15202343 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.14097837 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.14097837 |
| 57 | MP0008004_abnormal_stomach_pH | 1.14068676 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.12453656 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.11377788 |
| 60 | MP0001853_heart_inflammation | 1.11207697 |
| 61 | MP0005166_decreased_susceptibility_to | 1.10760131 |
| 62 | MP0000343_altered_response_to | 1.10656657 |
| 63 | MP0001851_eye_inflammation | 1.07678466 |
| 64 | MP0003828_pulmonary_edema | 1.04393832 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.04231733 |
| 66 | MP0002132_abnormal_respiratory_system | 1.01505824 |
| 67 | MP0004883_abnormal_blood_vessel | 1.00688673 |
| 68 | MP0002933_joint_inflammation | 0.99986023 |
| 69 | MP0005390_skeleton_phenotype | 0.98178204 |
| 70 | MP0003690_abnormal_glial_cell | 0.96053687 |
| 71 | MP0000604_amyloidosis | 0.94757652 |
| 72 | MP0009763_increased_sensitivity_to | 0.94305256 |
| 73 | MP0005164_abnormal_response_to | 0.92530271 |
| 74 | MP0009840_abnormal_foam_cell | 0.92185660 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.85223304 |
| 76 | MP0001663_abnormal_digestive_system | 0.85194701 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.84693459 |
| 78 | MP0002332_abnormal_exercise_endurance | 0.82681129 |
| 79 | MP0002396_abnormal_hematopoietic_system | 0.81836714 |
| 80 | MP0002006_tumorigenesis | 0.78705056 |
| 81 | MP0000490_abnormal_crypts_of | 0.75846927 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 0.74714323 |
| 83 | MP0004130_abnormal_muscle_cell | 0.69880262 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.67759342 |
| 85 | MP0000249_abnormal_blood_vessel | 0.64765996 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.63460406 |
| 87 | MP0003795_abnormal_bone_structure | 0.63416173 |
| 88 | MP0008874_decreased_physiological_sensi | 0.62360455 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.60567718 |
| 90 | MP0003045_fibrosis | 0.60307426 |
| 91 | MP0002254_reproductive_system_inflammat | 0.60078345 |
| 92 | MP0001542_abnormal_bone_strength | 0.58973171 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.58813242 |
| 94 | MP0003091_abnormal_cell_migration | 0.55453752 |
| 95 | MP0003329_amyloid_beta_deposits | 0.52096299 |
| 96 | MP0000609_abnormal_liver_physiology | 0.50760685 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 0.50459491 |
| 98 | MP0002019_abnormal_tumor_incidence | 0.49742028 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.48485777 |
| 100 | MP0005076_abnormal_cell_differentiation | 0.47778184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.90710518 |
| 2 | Myositis (HP:0100614) | 6.18867220 |
| 3 | Orchitis (HP:0100796) | 5.86581849 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.80843684 |
| 5 | Optic neuritis (HP:0100653) | 5.80843684 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.37802669 |
| 7 | Recurrent abscess formation (HP:0002722) | 5.13440846 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.91952146 |
| 9 | Stomatitis (HP:0010280) | 4.91839208 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.80870016 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.16898535 |
| 12 | Keratoconjunctivitis sicca (HP:0001097) | 4.07573809 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.98751359 |
| 14 | T lymphocytopenia (HP:0005403) | 3.95992883 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.92098987 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.91181557 |
| 17 | Vasculitis (HP:0002633) | 3.83877868 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.80234741 |
| 19 | Meningitis (HP:0001287) | 3.78038040 |
| 20 | Encephalitis (HP:0002383) | 3.76175942 |
| 21 | Keratoconjunctivitis (HP:0001096) | 3.75412925 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 3.74127740 |
| 23 | Recurrent skin infections (HP:0001581) | 3.58317903 |
| 24 | Increased IgE level (HP:0003212) | 3.53613585 |
| 25 | Obstructive lung disease (HP:0006536) | 3.39481345 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.39481345 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.37766152 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.37766152 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.32042706 |
| 30 | Pustule (HP:0200039) | 3.28337352 |
| 31 | Pulmonary infiltrates (HP:0002113) | 3.20337234 |
| 32 | Recurrent viral infections (HP:0004429) | 3.17554385 |
| 33 | Abnormality of T cells (HP:0002843) | 3.15667833 |
| 34 | Increased IgM level (HP:0003496) | 3.12710998 |
| 35 | Hemoptysis (HP:0002105) | 3.12647668 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.01394151 |
| 37 | Leukocytosis (HP:0001974) | 2.95231056 |
| 38 | Urticaria (HP:0001025) | 2.91027523 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.90265098 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.90265098 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.90265098 |
| 42 | Gangrene (HP:0100758) | 2.85859689 |
| 43 | Gingivitis (HP:0000230) | 2.85560907 |
| 44 | Arterial thrombosis (HP:0004420) | 2.85552430 |
| 45 | Chest pain (HP:0100749) | 2.82132631 |
| 46 | IgG deficiency (HP:0004315) | 2.78279259 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.78110436 |
| 48 | Joint swelling (HP:0001386) | 2.73807217 |
| 49 | Cellulitis (HP:0100658) | 2.73403242 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.71884935 |
| 51 | Anorexia (HP:0002039) | 2.71654999 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.68366455 |
| 53 | Gastrointestinal stroma tumor (HP:0100723) | 2.65065660 |
| 54 | Granulocytopenia (HP:0001913) | 2.64492391 |
| 55 | Severe combined immunodeficiency (HP:0004430) | 2.58977156 |
| 56 | Recurrent bronchitis (HP:0002837) | 2.58898203 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.57725752 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.57665469 |
| 59 | Pulmonary embolism (HP:0002204) | 2.56442400 |
| 60 | Lymphopenia (HP:0001888) | 2.55749098 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.54501035 |
| 62 | Episodic fever (HP:0001954) | 2.52989800 |
| 63 | Petechiae (HP:0000967) | 2.52370845 |
| 64 | Colitis (HP:0002583) | 2.52258935 |
| 65 | Abnormality of the pleura (HP:0002103) | 2.50452257 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.48562814 |
| 67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42378021 |
| 68 | Eosinophilia (HP:0001880) | 2.37351075 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.36968569 |
| 70 | Abnormality of eosinophils (HP:0001879) | 2.35195840 |
| 71 | Stomach cancer (HP:0012126) | 2.35191488 |
| 72 | Epistaxis (HP:0000421) | 2.29273184 |
| 73 | Gingival bleeding (HP:0000225) | 2.28945466 |
| 74 | Increased serum ferritin (HP:0003281) | 2.27744376 |
| 75 | Increased cerebral lipofuscin (HP:0011813) | 2.27250308 |
| 76 | Acne (HP:0001061) | 2.24985780 |
| 77 | Glomerulopathy (HP:0100820) | 2.24154986 |
| 78 | Combined immunodeficiency (HP:0005387) | 2.22543800 |
| 79 | Sepsis (HP:0100806) | 2.21716811 |
| 80 | Hypochromic anemia (HP:0001931) | 2.20135358 |
| 81 | Osteomyelitis (HP:0002754) | 2.20006768 |
| 82 | Chronic otitis media (HP:0000389) | 2.19834143 |
| 83 | Purpura (HP:0000979) | 2.19308834 |
| 84 | Dysostosis multiplex (HP:0000943) | 2.18735460 |
| 85 | Abnormality of B cell number (HP:0010975) | 2.18731316 |
| 86 | Hematochezia (HP:0002573) | 2.18208298 |
| 87 | Arthralgia (HP:0002829) | 2.14718475 |
| 88 | IgM deficiency (HP:0002850) | 2.13633799 |
| 89 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10621346 |
| 90 | Loss of speech (HP:0002371) | 2.10570757 |
| 91 | Abnormality of the endocardium (HP:0004306) | 2.10273628 |
| 92 | Amyloidosis (HP:0011034) | 2.09296711 |
| 93 | Keratitis (HP:0000491) | 2.07100056 |
| 94 | Vacuolated lymphocytes (HP:0001922) | 2.06827180 |
| 95 | Vertigo (HP:0002321) | 2.05871471 |
| 96 | Premature loss of primary teeth (HP:0006323) | 2.03929403 |
| 97 | Polyneuropathy (HP:0001271) | 2.03862423 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.02776118 |
| 99 | Restrictive lung disease (HP:0002091) | 2.01539874 |
| 100 | Verrucae (HP:0200043) | 2.00177922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.31783116 |
| 2 | MAP4K1 | 4.23069870 |
| 3 | TXK | 3.29678178 |
| 4 | MAP3K14 | 3.04939560 |
| 5 | IRAK4 | 3.03780124 |
| 6 | TYK2 | 2.84744874 |
| 7 | BLK | 2.68091948 |
| 8 | GRK6 | 2.38663070 |
| 9 | IKBKE | 2.34939412 |
| 10 | CSK | 2.34788467 |
| 11 | ZAP70 | 2.34432108 |
| 12 | TBK1 | 2.34113356 |
| 13 | PRPF4B | 2.30504951 |
| 14 | TAOK3 | 2.20597257 |
| 15 | ERN1 | 2.12625822 |
| 16 | FES | 1.99419942 |
| 17 | TNK2 | 1.99279969 |
| 18 | MAP3K13 | 1.98438733 |
| 19 | JAK3 | 1.92473250 |
| 20 | JAK1 | 1.82711330 |
| 21 | MAP2K3 | 1.79063969 |
| 22 | FGR | 1.78016681 |
| 23 | IKBKB | 1.75318147 |
| 24 | BTK | 1.75217477 |
| 25 | SYK | 1.67090744 |
| 26 | BMPR2 | 1.56239406 |
| 27 | SIK3 | 1.54934994 |
| 28 | IRAK3 | 1.53918727 |
| 29 | MAP3K11 | 1.51564632 |
| 30 | HCK | 1.45442387 |
| 31 | RIPK1 | 1.44972104 |
| 32 | TAOK1 | 1.42293864 |
| 33 | LYN | 1.35480734 |
| 34 | EPHB1 | 1.34567331 |
| 35 | MAP3K3 | 1.32104234 |
| 36 | LCK | 1.31247796 |
| 37 | JAK2 | 1.24400351 |
| 38 | GRK7 | 1.22939761 |
| 39 | MATK | 1.22757809 |
| 40 | TAOK2 | 1.21942890 |
| 41 | MARK3 | 1.19809816 |
| 42 | CSF1R | 1.17678003 |
| 43 | ITK | 1.13261877 |
| 44 | KIT | 1.05666500 |
| 45 | SIK2 | 1.01851748 |
| 46 | IRAK1 | 0.97978826 |
| 47 | MAP3K1 | 0.96801135 |
| 48 | IRAK2 | 0.94245135 |
| 49 | TESK2 | 0.89807275 |
| 50 | MARK2 | 0.86742032 |
| 51 | STK10 | 0.84249734 |
| 52 | CDC42BPA | 0.82905111 |
| 53 | PRKD2 | 0.79384317 |
| 54 | TEC | 0.77610600 |
| 55 | PDK1 | 0.76187433 |
| 56 | PIM1 | 0.74501881 |
| 57 | MAP2K2 | 0.73945315 |
| 58 | MAP3K7 | 0.73301468 |
| 59 | MAPK7 | 0.72812264 |
| 60 | TRIB3 | 0.71884543 |
| 61 | CHUK | 0.71323799 |
| 62 | KSR2 | 0.66784079 |
| 63 | FGFR4 | 0.65576761 |
| 64 | FYN | 0.59049057 |
| 65 | PTK6 | 0.54655042 |
| 66 | PRKCQ | 0.54385808 |
| 67 | HIPK2 | 0.52959603 |
| 68 | TGFBR2 | 0.52846233 |
| 69 | MOS | 0.51499223 |
| 70 | MAPK12 | 0.51380135 |
| 71 | SIK1 | 0.50638532 |
| 72 | PDPK1 | 0.50547874 |
| 73 | RPS6KL1 | 0.46744378 |
| 74 | RPS6KC1 | 0.46744378 |
| 75 | YES1 | 0.43247432 |
| 76 | EPHA3 | 0.41573773 |
| 77 | MAP3K5 | 0.40814234 |
| 78 | RPS6KA6 | 0.40344198 |
| 79 | SMG1 | 0.40336977 |
| 80 | CDK4 | 0.39092201 |
| 81 | MAPK4 | 0.38217984 |
| 82 | DYRK1B | 0.36498415 |
| 83 | FGFR3 | 0.35098831 |
| 84 | MAP2K6 | 0.34345714 |
| 85 | PIK3CG | 0.32956274 |
| 86 | NLK | 0.32657487 |
| 87 | ADRBK2 | 0.31358348 |
| 88 | MAPK11 | 0.30595198 |
| 89 | CAMKK1 | 0.30500802 |
| 90 | LRRK2 | 0.28821160 |
| 91 | ABL1 | 0.28087383 |
| 92 | MAPKAPK2 | 0.27919413 |
| 93 | RPS6KA2 | 0.27644422 |
| 94 | CAMKK2 | 0.26190708 |
| 95 | CLK1 | 0.25974673 |
| 96 | NME2 | 0.25832073 |
| 97 | BMX | 0.25662383 |
| 98 | SGK3 | 0.25139074 |
| 99 | RPS6KA1 | 0.24518583 |
| 100 | PDGFRB | 0.24136878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.85728319 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.85258022 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.83574266 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81970885 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.77161233 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.46458965 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.39850953 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.36712347 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.36419091 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35985702 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.27684900 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25574296 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.14267815 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09253840 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.06372740 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.02894219 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.95361147 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.93283010 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.90765524 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.90633636 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82182467 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.76545625 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74946081 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67658115 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.64255430 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64062543 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.63541885 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58706599 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55709422 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.55512242 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54907506 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52969731 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52475714 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.50806215 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.47854704 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47282608 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46390831 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45642067 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43336375 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.33309346 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23437954 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23183385 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.18924696 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.18085366 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.04884110 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.03142588 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95511342 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.95454794 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94826051 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.92378517 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.88832092 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88337893 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83808368 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83432894 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81576426 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.77216455 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75286932 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72597419 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69943634 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68646896 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68151071 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67634719 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65069530 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62693026 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59521287 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58186498 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58087061 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.57960791 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56282150 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.54720510 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53148277 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51824914 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51767083 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51091244 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49423785 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49082113 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48352970 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.47054100 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45856357 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45447644 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42419493 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42163338 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38400488 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37561338 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36951734 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36329356 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36280133 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35088632 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34437196 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33161420 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32611159 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32218949 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30841019 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27602343 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.25088640 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.24860046 |
| 97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.21278204 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.20630163 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.18585660 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18040013 |

